Imagyn Laparoscopic Line Divestiture Lets Firm Focus On Oncology Devices
This article was originally published in The Gray Sheet
Executive Summary
Imagyn will use the nearly $30 mil. in proceeds from the sale of its minimal access surgery (MAS) products to Conmed to help launch three new oncology and critical care products.
You may also be interested in...
Conmed Adds Bionx To Sports Medicine Offerings, Tackling Polymer Pipeline
Conmed will continue to develop Bionx Implants' Self-Reinforced resorbable polymer technology at Bionx facilities in Blue Bell, Penn. and Tampere, Finland upon completion of its $48 mil. cash purchase of the firm, expected by this spring
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.